Viking Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
04 Jan 24 | SellUS$268,500 | Gregory Zante | Individual | 15,000 | US$17.90 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 18,891 | 0.0171% |
Individual Insiders | 2,336,094 | 2.12% |
Public Companies | 3,616,077 | 3.28% |
General Public | 25,384,233 | 23% |
Institutions | 78,912,915 | 71.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
15,004,340 | US$1.1b | 0% | 0.07% | |||
7,605,867 | US$581.3m | 6.66% | 0.01% | |||
5,732,990 | US$438.2m | -10.6% | 0.02% | |||
5,381,904 | US$411.3m | 1.85% | 0.01% | |||
5,145,112 | US$393.2m | 12.5% | 1.38% | |||
3,673,935 | US$280.8m | 3.49% | 0.09% | |||
3,616,077 | US$276.4m | 0% | no data | |||
2,243,523 | US$171.5m | 5.73% | 0.47% | |||
2,223,822 | US$170.0m | 0.98% | 0.09% | |||
2,128,343 | US$162.7m | 5.01% | 0.01% | |||
1,870,897 | US$143.0m | 6.24% | no data | |||
1,279,000 | US$97.8m | 0% | 1.92% | |||
1,269,370 | US$97.0m | 80.7% | 0.01% | |||
1,004,386 | US$76.8m | 0.1% | 4.5% | |||
916,380 | US$70.0m | -1.21% | 0.01% | |||
912,569 | US$69.7m | 0% | 0.42% | |||
859,691 | US$65.7m | 170% | 0.03% | |||
814,839 | US$62.3m | 30.9% | 0.01% | |||
775,699 | US$59.3m | 0% | 0.01% | |||
762,448 | US$58.3m | 11.2% | 0.03% | |||
750,000 | US$57.3m | 0% | 0.95% | |||
694,724 | US$53.1m | 6,010% | 0.04% | |||
663,155 | US$50.7m | 0% | 0.01% | |||
620,000 | US$47.4m | -0.8% | 4.18% | |||
612,274 | US$46.8m | 74.2% | 0.02% |